[Longitudinal study of a population of leprosy patients by the TML (leukocyte migration test)].
This is the report of an experiment of leucocyte migration performed with BCG and Lepromin among three groups of people: - one group of leprotic people; - two groups of witnesses. The first one including people with BBS disease having not received corticoid treatment. The reaction against Lepromin are different, among the leprotic group of people from the non leprotic one. We have noticed in the leprotic group variations with time depending on the kind of treatment. This is a fact very interesting to point out. These findings should be showed right or wrong by other physicians.
D002464:Cell Migration Inhibition; D006801:Humans; D007916:Lepromin / Q000276:immunology; D007918:Leprosy / Q000188:drug therapy / Q000276:immunology*; D007962:Leukocytes / Q000276:immunology*; D009163:Mycobacterium bovis / Q000276:immunology; D012293:Rifampin / Q000627:therapeutic use
D007916:Lepromin; D012293:Rifampin
Etude longitudinale d'une population de lépreux par le TML (test de migration leucocytaire).